Skip to content

VISTO MED

Active
Private limited companyfounded 2018active for 7 yearsVoie de Liège(AYE) 6, 4630 Soumagne, BelgiumKBO/BCE: BE 0715.972.044
Summary

VISTO MED has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €107,160 and a net result of €32,007. Equity is growing by about 20% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
VISTO MEDActiveChecked score 92/100
Risk analysis ReportCompare

Overview

Activity
Activity not known2 sites
Size
€265,549total assets 2025
Equity
€107,160
Profit
€32,007
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Accounts 74 days early0 of 2 deeds read
Why 92raises riskFounded in 2018lowers riskSize: total assets €265,549Liquidity: current ratio 1.43, cash €145,942No main activity registeredShow the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (no NACE code, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 65-35
equity 40.4% of total assets
Liquidity 69-25
short-term debt 59.6% · cash 55.0%
Profitability 84+2
return on assets 12.1%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025highest value 05-2025: < 0.1%▼ -0.2 percentage points vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.43, compared with 4.16 in 2024, below the usual 1.5; short-term debt: 59.6% and cash: 55% of total assets), and 59.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 39% on solvency, 65% on liquidity, 67% on profitability and 9% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €265,549
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.43, cash €145,942
NBB · annual accounts
lowers risk · No main activity registered
KBO
raises risk · Founded in 2018
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-05-2026, 74 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
74 days early
2024
100 days early
2023
58 days early
2022
52 days early
2021
41 days early
2020
17 days early
2019
46 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 55 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 May (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Annual accounts filedfinancial year 2023 · full…

Key points

  • Caution: Equity fell in 2025from €231,083 to €107,160 ▼ 53.6% View
  • Positive: Always filed on timeaccounts within the deadline every year 7 years View
  • Positive: 7 profitable years in a rowprofit 2025: €32,007 7 years View

By topic

Financials

Financial year
2025
Total assets
€265,549
Profit
€32,007
Solvency
40.4%
Total assets▼ 7.6%
Net result
20192025
Go to Financials

Timeline

Events
14
Since
2019
Next accounts
by 31-07-2027
  1. 31-12-2023Weakest financial year
  2. 09-06-2023Annual accounts filed
  3. 31-12-2022Liquidity more than 7 times
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Founded
18-12-2018
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about VISTO MED

What is the company number of VISTO MED?
0715.972.044. In Belgium the VAT number is the company number with BE in front: BE 0715.972.044.
Where is VISTO MED based?
The registered office is at Voie de Liège(AYE) 6, 4630 Soumagne.Company details
What is the legal form of VISTO MED?
Private limited company (BV).
When was VISTO MED founded?
On 18-12-2018.
Is VISTO MED still active?
Yes, VISTO MED is an active enterprise in the KBO register.
What is the turnover of VISTO MED?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is VISTO MED profitable?
In financial year 2025, VISTO MED made a profit of €32,007.
Where can I find the annual accounts of VISTO MED?
VISTO MED filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VISTO MED due?
By 31-07-2027, for financial year 2026.Timeline

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure